VoLassom Calcium (CaHA) 0.8mL x 2

Volassom is an advanced dermal filler formulated with calcium hydroxyapatite (CaHA), boasting a unique Lattice-pore technology for superior results. Each syringe contains CaHA microspheres suspended in a gel carrier, composed of carboxymethyl cellulose, glycerol, and water, ensuring a homogeneous gel structure. These microspheres act as a scaffold, promoting the natural synthesis of collagen for a rejuvenated appearance.

Key Features:

• Immediate skin lifting effect for instant rejuvenation
• Long-lasting results lasting 1.5 to 2 years
• Stimulates the production of endogenous collagen, enhancing skin elasticity and firmness
• Minimizes the risk of filler migration with innovative Lattice-pore technology
• Easy to inject, evenly distributed, and biodegraded in the dermis due to uniform CaHA microsphere homogeneity
• Completely biocompatible, biodegradable, and non-toxic, eliminating the need for pre-procedure skin testing

Recommended Use: Volassom is ideal for correcting moderate-to-severe wrinkles, folds, and facial volume loss. Administered via injection into the mid-to-deep dermis, it provides comprehensive facial rejuvenation for a youthful appearance.

Main Ingredients:

• 30% Calcium Hydroxylapatite (CaHA) microspheres (30 µm)
• 70% Polymer Gel Carrier (Carboxymethyl Cellulose, Glycerol, Water)

Packing Unit: Each package includes 2 prefilled syringes, each containing 0.8ml of the advanced Volassom formula.

CE1023 certified
Volassom’s elasticity makes it resistant to forces such as facial muscles, which provides an extremely stable effect.

Storage Ability
VoLassom Calcium Hydroxylapatite (CaHA) is a dermal filler used primarily for facial volume restoration and contouring. The storage conditions for this product are critical to maintain its efficacy and safety. Typically, CaHA fillers should be stored in a cool, dry place away from direct sunlight. The recommended storage temperature is between 2°C to 25°C (36°F to 77°F). It is essential to keep the product in its original packaging until use to protect it from contamination and degradation. Additionally, once opened, the filler should be used promptly as exposure to air can compromise its integrity.

Side Effects
As with any injectable filler, VoLassom Calcium may have side effects. Common side effects include:

1. Injection Site Reactions: These can manifest as swelling, redness, pain, or bruising at the injection site. These reactions are usually mild and resolve within a few days.

2. Nodules or Lumps: Occasionally, patients may experience palpable nodules or lumps under the skin where the filler was injected. This can occur if the filler is not evenly distributed during injection.

3. Allergic Reactions: Although rare, some individuals may experience allergic reactions to the components of the filler.

4. Infection: As with any procedure involving injections, there is a risk of infection at the injection site.

5. Vascular Complications: In very rare cases, if the filler is inadvertently injected into a blood vessel, it can lead to serious complications such as tissue necrosis or vision problems.

Patients are advised to discuss potential side effects with their healthcare provider before undergoing treatment.

Advantages
VoLassom Calcium offers several advantages that make it a popular choice among practitioners and patients:

1. Natural-Looking Results: CaHA fillers provide a more natural appearance compared to some other fillers because they integrate well with surrounding tissues.

2. Long-Lasting Effects: The results from CaHA fillers typically last longer than hyaluronic acid fillers—often up to 12 months or more—due to their unique composition that stimulates collagen production in addition to providing immediate volume.

3. Biocompatibility: Being composed of calcium hydroxylapatite—a substance naturally found in human bones—makes this filler biocompatible and reduces the risk of adverse reactions.

4. Versatility: VoLassom Calcium can be used for various applications including cheek augmentation, jawline definition, and treating nasolabial folds.

5. Minimal Downtime: Most patients experience minimal downtime after treatment with CaHA fillers; many return to their normal activities shortly after the procedure.